Increase in interleukin-6 in the first hour after coronary stenting: An early marker of the inflammatory response

被引:39
作者
Aggarwal, A [1 ]
Schneider, DJ [1 ]
Terrien, EF [1 ]
Gilbert, KE [1 ]
Dauerman, HL [1 ]
机构
[1] Univ Vermont, Coll Med, FAHC, Cardiol Unit, Burlington, VT 05401 USA
关键词
inflammation; stents; revascularization;
D O I
10.1023/A:1026188200939
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Inflammation after coronary stenting presages adverse outcomes after percutaneous coronary intervention (PCI). While changes in inflammatory markers have been defined 24-72 hours after PCI, potential changes during the first few hours have not. This study was designed to determine if a systemic inflammatory response could be measured within the first hour after stenting. Methods: Patients (n = 25) undergoing coronary stenting, with predominantly (n = 23) acute coronary syndromes were enrolled prospectively in this registry. Blood samples were collected before PCI, and 10 minutes, 1 hour and 18-24 hours later. No patient received a glycoprotein IIb-IIIa inhibitor. Concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1 receptor antagonist (IL-1Ra) and soluble CD40 ligand (sCD40L) were measured using ELISA. Results: CRP and sCD40L did not change in the first hour after stenting. By contrast, IL-6 increased in the first hour (before = 7.6 +/- 7.7 pg/ml, 1 hour = 12 +/- 12 pg/ml; p < 0.001). The concentration of IL-1Ra tended to be greater after 1 hour (before = 426 +/- 261 pg/ml, 1 hour = 511 +/- 406 pg/ml; p = 0.11). Increase in IL-1Ra was apparent only in female subjects (p = 0.004 for the difference in trend between the two genders). A correlation was not observed between the increase in IL-6 at 1 hour and the increase in CRP at 24 hours (r = -0.21). Conclusions: In patients undergoing coronary stenting, increase in IL-6 can be detected 1 hour after PCI, and thus IL-6 may be an early initiator of the systemic inflammatory response to stenting.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 27 条
[21]   Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention [J].
Patti, G ;
Di Sciascio, G ;
D'Ambrosio, A ;
Dicuonzo, G ;
Abbate, A ;
Dobrina, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04) :372-376
[22]   Long-term effects of pravastatin on plasma concentration of C-reactive protein [J].
Ridker, PM ;
Rifai, N ;
Pfeffer, MA ;
Sacks, F ;
Braunwald, E .
CIRCULATION, 1999, 100 (03) :230-235
[23]  
*SAS I INC, 1985, SAS PROC GUID PERS C
[24]   Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) [J].
Steg, PG ;
Goldberg, RJ ;
Gore, JM ;
Fox, KAA ;
Eagle, KA ;
Flather, MD ;
Sadiq, I ;
Kasper, R ;
Rushton-Mellor, SK ;
Anderson, FA .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) :358-363
[25]  
VANDEVENTER SJH, 1990, BLOOD, V76, P2520
[26]   Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation [J].
Walter, DH ;
Fichtlscherer, S ;
Sellwig, M ;
Auch-Schwelk, W ;
Schächinger, V ;
Zeiher, AN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) :839-846
[27]   Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management [J].
Zanger, D ;
Yang, BK ;
Ardans, J ;
Waclawiw, MA ;
Csako, G ;
Wahl, LM ;
Cannon, RO .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1797-1802